Home  » Topic

Sun Pharma News

Sun Pharma Stock Up, Settles Patent Litigation For Generic Revlimid
Sun Pharmaceutical Industries Limited along with one of its wholly owned subsidiaries today announced that they have reached an agreement with Celgene Corporation (Celgene), a wholly-owned subsidiary of Bristol Myers Squibb, to resolve the patent litigation regarding submission of an Abbreviated ...
Sun Pharma Stock Up Settles Patent Litigation For Generic Revlimid

10 Stock Picks From HDFC Securities For 2021
2020 has been a dramatic year even for the stock markets. From the sharp drop seen in March amid the peak of the COVID-19 panic, stocks have recovered gradually causing benchmark indices to hit new all-time highs as the year comes ...
Stock Picks From Hdfc Securities For
3 Year-End Stock Picks That Can Boost Your Portfolio
Markets have rallied a fair bit and have given decent returns from current levels. It's time to pick good quality stocks as the year comes to an end. Here are three stocks that can yield decent returns from the current levels, ...
Year End Stock Picks That Can Boost Your Portfolio
4 Pharma Stocks That Look Promising For The Long Term
Pharma has been among the best performing sectors in 2020, due to anticipation on reporting higher revenue amid the pandemic. In a once in a century kind of health crisis, the pharma industry in India, which is the largest provider of ...
Sun Pharma Q4 Profit Falls 37% On One-Time Expenditure
On Wednesday, Sun Pharmaceutical Industries reported a 37.1 percent decline in consolidated profit of Rs 399.8 crore for the March ended quarter due to a one-time loss of Rs 260.6 crore. The company wrote an amount of Rs 104.28 crore, including ...
Sun Pharma Q4 Profit Falls 37 On One Time Expenditure
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X